PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 26, 2026BMJ Open0 citationsOpen Access

Priorities for the development of a new rapid diagnostic test for patients with fever: a cross-sectional online survey among hospital physicians across Europe

View Full Paper
GBGabrielle BonnetMNMaryke Joanne NielsenAFAnna M. Foss

Key Points

  • The aim is to identify hospital doctors’ priorities for developing a rapid diagnostic test for fever in patients.
  • Cross-sectional online survey conducted among secondary and tertiary care doctors.
  • Survey ran from April to September 2024 across Europe.
  • Collected data on priorities for up to 19 use cases and aetiologies related to febrile presentations.
  • 265 respondents from 30 European countries participated in the survey analysis.
  • Top priorities included febrile immunocompromised patients and fever without a focus.
  • 92% of respondents found a generic test for bacterial aetiology useful.
  • 54% found a generic test for inflammatory aetiology useful, particularly for diagnosing Kawasaki’s disease.
  • 83% would find a generic test useful when used alongside a specific test for Kawasaki’s disease.

Abstract

Objective This study aimed to understand hospital doctors’ priorities (target use cases and aetiologies) for the development of a new rapid diagnostic test for patients with fever. Design A cross-sectional online survey. Setting Europe-wide. Participants Secondary and tertiary care doctors involved in patient assessment and diagnosis across Europe. Intervention Online survey from April to September 2024. Main outcome measures Importance of developing a new test on a scale of 1–10 for up to 19 ‘use cases’ (types of febrile presentations in specific demographic groups): use case scores and ranks and differences across subgroups of respondents, with free text to capture additional suggestions; respondents’ preferences (multiple choice) regarding which aetiologies should be included in a new test. Results 265 respondents from 30 European countries (out of 270 starting the survey) were included in the analysis. Top priorities included febrile immunocompromised patients and fever without a focus for both paediatric and adult use cases, and 1–3 months old febrile infants. Rankings were similar across clinician subgroups despite some differences in average scores. 92% (243/263), 95% CI 89% to 95%, of respondents would find a ‘generic’ test for bacterial aetiology useful, even if it does not differentiate between Gram-positive and Gram-negative aetiologies. 54% (63/116), 95% CI 45% to 63%, of respondents would find a ‘generic’ test for inflammatory aetiology useful when seeking to diagnose children for whom Kawasaki’s disease (KD) is on the differential, even in the absence of any KD-specific test, 83% (96/116), 95% CI 75% to 89%, would find such a ‘generic’ test useful if they could use it alongside a KD test when desired. Conclusion Clinicians prioritise the most vulnerable patients (because of age or comorbidities) and unclear presentations (fever without a focus) for the development of a new fever diagnostic test. Even relatively simple (eg, bacterial, inflammatory) tests could provide added value to most clinicians.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bonnet et al. (2026) studied this question.

synapsesocial.com/papers/69c4ccc9fdc3bde448918516https://doi.org/10.1136/bmjopen-2025-107663
Ask AI
Helpful
Bookmark
Share
View Full Paper